Literature DB >> 15489490

Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid.

R H Y Asaria1, C H Kon, C Bunce, C S Sethi, G A Limb, P T Khaw, G W Aylward, D G Charteris.   

Abstract

AIM: To determine whether silicone oil concentrates protein and growth factors in the retro-oil fluid.
METHODS: A laboratory analysis of intraocular fluid and vitreous specimens obtained from patients undergoing removal of silicone oil, revision vitrectomy, or primary vitrectomy for macular hole, proliferative vitreoretinopathy (PVR), or retinal detachment. Patients were prospectively recruited from routine vitreoretinal operating lists. Vitreous cavity fluid and vitreous samples were analysed for the presence of transforming growth factor beta (TGF-beta2), basic fibroblast growth factor (bFGF), interleukin 6 (IL-6), and total protein using either commercially available enzyme linked immunosorbent assays (ELISA) or protein assay kits.
RESULTS: The median levels of bFGF, IL-6, and protein in the retro-oil fluid were raised (p<0.05) compared to all the other vitreous and vitreous cavity fluid samples. bFGF, IL-6, and protein levels were raised in PVR vitreous compared to non-PVR vitreous. TGF-beta2 levels were not significantly raised in retro-oil fluid or in PVR vitreous.
CONCLUSIONS: The concentration of fibrogenic (bFGF) and inflammatory (IL-6) growth factors and protein is raised in retro-silicone oil fluid. This may contribute to the process of retro-oil perisilicone proliferation and subsequent fibrocellular membrane formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489490      PMCID: PMC1772397          DOI: 10.1136/bjo.2003.040402

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  The use of liquid silicone in retinal detachment surgery.

Authors:  P A CIBIS; B BECKER; E OKUN; S CANAAN
Journal:  Arch Ophthalmol       Date:  1962-11

2.  A long-term evaluation of silicone retinopathy in monkeys.

Authors:  N Mukai; P F Lee; M Oguri; C L Schepens
Journal:  Can J Ophthalmol       Date:  1975-07       Impact factor: 1.882

3.  Silicone oil in the treatment of complicated retinal detachments.

Authors:  J H Yeo; B M Glaser; R G Michels
Journal:  Ophthalmology       Date:  1987-09       Impact factor: 12.079

4.  Intravitreous injection of silicone: an experimental study. II. Histochemistry and electron microscopy.

Authors:  N Mukai; P F Lee; C L Schepens
Journal:  Ann Ophthalmol       Date:  1972-04

5.  Intravitreal surgery utilizing liquid silicone. A long term followup.

Authors:  E Okun
Journal:  Trans Pac Coast Otoophthalmol Soc Annu Meet       Date:  1968

6.  Recent methods in the surgical treatment of retinal detachment: intravitreal procedures.

Authors:  P A Cibis
Journal:  Trans Ophthalmol Soc U K       Date:  1965

7.  Silicone oil for the treatment of severe proliferative diabetic retinopathy.

Authors:  N D Brourman; M S Blumenkranz; M S Cox; M T Trese
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079

8.  Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial.

Authors:  R H Asaria; C H Kon; C Bunce; D G Charteris; D Wong; P T Khaw; G W Aylward
Journal:  Ophthalmology       Date:  2001-07       Impact factor: 12.079

9.  Perisilicone proliferation after vitrectomy for proliferative vitreoretinopathy.

Authors:  H Lewis; J M Burke; G W Abrams; T M Aaberg
Journal:  Ophthalmology       Date:  1988-05       Impact factor: 12.079

10.  Effect of silicone oil on experimental traction retinal detachment.

Authors:  F H Lambrou; J M Burke; T M Aaberg
Journal:  Arch Ophthalmol       Date:  1987-09
View more
  45 in total

1.  Immunopathology of intraocular silicone oil: retina and epiretinal membranes.

Authors:  Louisa J Wickham; Riaz H Asaria; Robert Alexander; Phil Luthert; David G Charteris
Journal:  Br J Ophthalmol       Date:  2006-09-27       Impact factor: 4.638

2.  Growth factors outside the PDGF family drive experimental PVR.

Authors:  Hetian Lei; Gisela Velez; Peter Hovland; Tatsuo Hirose; Debra Gilbertson; Andrius Kazlauskas
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-25       Impact factor: 4.799

3.  Clinical and histological features of epiretinal membrane after diabetic vitrectomy.

Authors:  Yung-Ray Hsu; Chung-May Yang; Po-Ting Yeh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-15       Impact factor: 3.117

4.  The use of silicone oil-RMN3 (Oxane HD) as heavier-than-water internal tamponade in complicated inferior retinal detachment surgery.

Authors:  Louisa Wickham; Paris Tranos; Paul Hiscott; David Charteris
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-27       Impact factor: 3.117

5.  Novel technique for silicone oil retention suture with secondary auto capsulotomy of fibrin membrane.

Authors:  R Wong; E J K Lee; M Shunmugam
Journal:  Eye (Lond)       Date:  2012-12-14       Impact factor: 3.775

6.  Central scotoma associated with intraocular silicone oil tamponade develops before oil removal.

Authors:  E N Herbert; M Habib; D Steel; T H Williamson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-27       Impact factor: 3.117

Review 7.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

8.  Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease.

Authors:  Steven Pennock; David Kim; Shizuo Mukai; Matthew Kuhnle; Dal W Chun; Joanne Matsubara; Jing Cui; Patrick Ma; David Maberley; Arif Samad; Robert J Van Geest; Sarit L Oberstein; Reinier O Schlingemann; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2013-04-09       Impact factor: 4.307

9.  Vision loss associated with the use and removal of intraocular silicone oil.

Authors:  Patrick D Williams; Christopher G Fuller; Ingrid U Scott; Dwain G Fuller; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2008-12

Review 10.  Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy.

Authors:  Hetian Lei; Marc-Andre Rheaume; Andrius Kazlauskas
Journal:  Exp Eye Res       Date:  2009-11-25       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.